THYRITOPE BIOSCIENCES
Thyritope Biosciences is developing therapeutics that target thyroid stimulating auto-antibodies, which are the causative drivers of Graves' hyperthyroidism and Graves' orbitopathy. Graves' disease is an autoimmune disorder caused by antibodies that over-stimulate the thyroid, causing excessive thyroid hormone production. The same antibodies stimulate the tissue around the eyes, resulting in an increase of orbital fat and extra-ocular muscle volume which causes the bulging of the eyes characteristic of Graves' orbitopathy.
THYRITOPE BIOSCIENCES
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
San Diego, California, United States
Country:
United States
Status:
Active
Total Funding:
10 M USD
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Employees Featured
Founder
Investors List
GlaxoSmithKline
GlaxoSmithKline investment in Series A - Thyritope Biosciences
Avalon Ventures
Avalon Ventures investment in Series A - Thyritope Biosciences